SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-23-000056
Filing Date
2023-05-11
Accepted
2023-05-11 16:12:08
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM 10-Q cdtx-20230331.htm   iXBRL 10-Q 1363547
2 SEVENTH AMENDMENT TO LEASE exhibit1012023-03.htm EX-10.1 9445
3 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3112023-03.htm EX-31.1 9946
4 CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3122023-03.htm EX-31.2 9955
5 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3212023-03.htm EX-32.1 7450
6 CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3222023-03.htm EX-32.2 7518
  Complete submission text file 0001610618-23-000056.txt   6053725

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20230331.xsd EX-101.SCH 38512
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20230331_cal.xml EX-101.CAL 44762
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20230331_def.xml EX-101.DEF 228694
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20230331_lab.xml EX-101.LAB 525952
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20230331_pre.xml EX-101.PRE 341142
53 EXTRACTED XBRL INSTANCE DOCUMENT cdtx-20230331_htm.xml XML 858662
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 23911141
SIC: 2836 Biological Products, (No Diagnostic Substances)